Purpose: To describe a systematic review of population-based prevalence studies of visual impairment (VI) and blindness worldwide over the past 32 years that informs the Global Burden of Diseases, Injuries and Risk Factors Study. Methods: A systematic review (Stage 1) of medical literature from 1 January 1980 to 31 January 2012 identified indexed articles containing data on incidence, prevalence and causes of blindness and VI. Only cross-sectional population-based representative studies were selected from which to extract data for a database of age- and sex-specific data of prevalence of four distance and one near vision loss categories (presenting and best-corrected). Unpublished data and data from studies using rapid assessment method...
Background: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of ...
Background: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of ...
Purpose : The Vision Loss Expert Group (VLEG) and Global Burden of Disease Study (GBD) collaborative...
Purpose: To describe a systematic review of population-based prevalence studies of visual impairment...
Purpose: To describe a systematic review of population-based prevalence studies of visual impairment...
Purpose: To describe a systematic review of population-based prevalence studies of visual impairment...
Purpose: To describe a systematic review of population-based prevalence studies of visual impairment...
Purpose: Vision impairment is a leading and largely preventable cause of disability worldwide. Howev...
Objective. To improve the accuracy of the global burden estimate of vision loss, this presentation s...
Background: Contemporary data on causes of vision impairment and blindness form an important basis ...
Introduction Vision impairment (VI) places a burden on individuals, health systems and society in ge...
Background: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of ...
Objective. This presentation shall describe the GBD, with emphasis on the global prevalence trends i...
Abstract The Global Burden of Disease study estimates the prevalence of vision loss...
PURPOSE: To estimate the number of people visually impaired or blind due to macular diseases except ...
Background: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of ...
Background: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of ...
Purpose : The Vision Loss Expert Group (VLEG) and Global Burden of Disease Study (GBD) collaborative...
Purpose: To describe a systematic review of population-based prevalence studies of visual impairment...
Purpose: To describe a systematic review of population-based prevalence studies of visual impairment...
Purpose: To describe a systematic review of population-based prevalence studies of visual impairment...
Purpose: To describe a systematic review of population-based prevalence studies of visual impairment...
Purpose: Vision impairment is a leading and largely preventable cause of disability worldwide. Howev...
Objective. To improve the accuracy of the global burden estimate of vision loss, this presentation s...
Background: Contemporary data on causes of vision impairment and blindness form an important basis ...
Introduction Vision impairment (VI) places a burden on individuals, health systems and society in ge...
Background: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of ...
Objective. This presentation shall describe the GBD, with emphasis on the global prevalence trends i...
Abstract The Global Burden of Disease study estimates the prevalence of vision loss...
PURPOSE: To estimate the number of people visually impaired or blind due to macular diseases except ...
Background: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of ...
Background: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of ...
Purpose : The Vision Loss Expert Group (VLEG) and Global Burden of Disease Study (GBD) collaborative...